Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DROXIDOPA vs EPINEPHRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DROXIDOPA vs EPINEPHRINE: Safety Overview

Metric DROXIDOPA EPINEPHRINE
Total FAERS Reports 20,119 15,112
Deaths Reported 2,500 1,469
Death Rate 12.4% 9.7%
Hospitalizations 2,900 4,388
Average Patient Age 67.7 yrs 43.5 yrs
% Female Patients 46.7% 58.7%
FDA Approval Date Apr 28, 2021 Approved Prior to Jan 1, 1982
Manufacturer Aurobindo Pharma Limited Henry Schein, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued